LADENBURG THALMANN FINANCIAL SERVICES INC. - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 36 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,0000.0%1,0000.0%0.00%
Q1 2019$1,0000.0%1,0000.0%0.00%
Q4 2018$1,0000.0%1,0000.0%0.00%
Q3 2018$1,0000.0%1,000
+100.0%
0.00%
Q2 2015$1,0005000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 85,378$301,0000.33%
Tower Research Capital LLC (TRC) 54,690$193,0000.03%
Psagot Value Holdings Ltd. 54,348$191,0000.01%
OPPENHEIMER & CO INC 36,450$128,0000.00%
MEEDER ASSET MANAGEMENT INC 2,900$10,0000.00%
TWO SIGMA INVESTMENTS, LP 34,571$121,0000.00%
Commonwealth Equity Services, Inc 11,100$39,0000.00%
GROUP ONE TRADING, L.P. 18,844$66,0000.00%
CITIGROUP INC 737$3,0000.00%
VAN ECK ASSOCIATES CORP 21,179$75,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders